ClearPoint Neuro (CLPT) Change in Acquisitions & Divestments (2022)

ClearPoint Neuro (CLPT) reported Change in Acquisitions & Divestments of $12.0 million for Q4 2022.

ClearPoint Neuro (CLPT) Change in Acquisitions & Divestments (2022) Analysis & Trends

ClearPoint Neuro (CLPT) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $12.0 million in Q4 2022.

  • For the quarter ending Q4 2022, Change in Acquisitions & Divestments changed N/A year-over-year to $12.0 million; the trailing twelve-month figure through Sep 2024 stood at $12.0 million (changed N/A YoY), and the FY2023 full-year result was $10.0 million, down 16.67% from the prior year.
  • Change in Acquisitions & Divestments was little changed at $12.0 million in Q4 2022.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $12.0 million in Q4 2022 to a low of $12.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 181.51 Bn 174.21 Bn 6.27 Bn
2 Stryker 128.52 Bn 125.64 Bn 3.81 Bn
3 Medtronic 108.06 Bn 98.84 Bn 6.41 Bn
4 Boston Scientific 68.04 Bn 66.59 Bn 3.61 Bn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn
6 GE HealthCare Technologies 28.45 Bn 26.17 Bn 1.98 Bn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn
8 Smith & Nephew 26.88 Bn 26.30 Bn -
9 Koninklijke Philips 25.42 Bn 22.29 Bn 2.07 Bn
10 ClearPoint Neuro 426.44 Mn 390.84 Mn 7.76 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 12.00 Mn
Dec 31, 2022 12.00 Mn